Cargando…
CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer’s disease
Impaired brain glucose uptake and metabolism precede the appearance of clinical symptoms in Alzheimer disease (AD). Neuronal glucose transporter 3 (GLUT3) is decreased in AD brain and correlates with tau pathology. However, what leads to the decreased GLUT3 is yet unknown. In this study, we found th...
Autores principales: | Jin, Nana, Qian, Wei, Yin, Xiaomin, Zhang, Lan, Iqbal, Khalid, Grundke-Iqbal, Inge, Gong, Cheng-Xin, Liu, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597642/ https://www.ncbi.nlm.nih.gov/pubmed/23341039 http://dx.doi.org/10.1093/nar/gks1227 |
Ejemplares similares
-
Memantine Attenuates Alzheimer’s Disease-Like Pathology and Cognitive Impairment
por: Wang, Xiaochuan, et al.
Publicado: (2015) -
Dysregulation of Protein Phosphorylation/Dephosphorylation
in Alzheimer's Disease: A Therapeutic Target
por: Gong, Cheng-Xin, et al.
Publicado: (2006) -
Neurogenic and Neurotrophic Effects of BDNF Peptides in Mouse Hippocampal Primary Neuronal Cell Cultures
por: Cardenas-Aguayo, Maria del Carmen, et al.
Publicado: (2013) -
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
por: Iqbal, K, et al.
Publicado: (2008) -
Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A
por: Qian, Wei, et al.
Publicado: (2011)